The development of menin inhibitors in AML and ALL

The development of menin inhibitors in AML and ALL

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical advances in hematology & oncology 2024-05, Vol.22 (4), p.185-187
1. Verfasser: Issa, Ghayas C
Format: Artikel
Sprache:eng
Schlagworte:
Antineoplastic Agents - pharmacology
Antineoplastic Agents - therapeutic use
Humans
Leukemia, Myeloid, Acute - drug therapy
Leukemia, Myeloid, Acute - metabolism
Proto-Oncogene Proteins - antagonists & inhibitors
Proto-Oncogene Proteins - metabolism
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 187
container_issue 4
container_start_page 185
container_title Clinical advances in hematology & oncology
container_volume 22
creator Issa, Ghayas C
description
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3054839787</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3054839787</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-631c48c26978e79e0f70095d8657290aabd93bba8ee85de16562b4b960676c4d3</originalsourceid><addsrcrecordid>eNo1j8tKxDAYRrNQnLH6CpKlm0Lul2UZvEEGN-O6JM1fJtKbTSv49hYcV-dbfBw4V2hPpeAl0Zbs0G3On4QIqpm6QTtuNLeasT1ipzPgCN_QjVMPw4LHFm9MA07DOYW0jHPeJq6ODvsh4sq5O3Td-i7D_YUF-nh-Oh1eS_f-8naoXDkxSpdScdoI0zBltQFtgbSaECujUVIzS7wP0fIQvAEwMgJVUrEgglVEadWIyAv0-Oed5vFrhbzUfcoNdJ0fYFxzzYkUZsvYWgr0cLmuoYdYT3Pq_fxT_3fyX9wQSyA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3054839787</pqid></control><display><type>article</type><title>The development of menin inhibitors in AML and ALL</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Issa, Ghayas C</creator><creatorcontrib>Issa, Ghayas C</creatorcontrib><identifier>ISSN: 1543-0790</identifier><identifier>PMID: 38739722</identifier><language>eng</language><publisher>United States</publisher><subject>Antineoplastic Agents - pharmacology ; Antineoplastic Agents - therapeutic use ; Humans ; Leukemia, Myeloid, Acute - drug therapy ; Leukemia, Myeloid, Acute - metabolism ; Proto-Oncogene Proteins - antagonists &amp; inhibitors ; Proto-Oncogene Proteins - metabolism</subject><ispartof>Clinical advances in hematology &amp; oncology, 2024-05, Vol.22 (4), p.185-187</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38739722$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Issa, Ghayas C</creatorcontrib><title>The development of menin inhibitors in AML and ALL</title><title>Clinical advances in hematology &amp; oncology</title><addtitle>Clin Adv Hematol Oncol</addtitle><subject>Antineoplastic Agents - pharmacology</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Humans</subject><subject>Leukemia, Myeloid, Acute - drug therapy</subject><subject>Leukemia, Myeloid, Acute - metabolism</subject><subject>Proto-Oncogene Proteins - antagonists &amp; inhibitors</subject><subject>Proto-Oncogene Proteins - metabolism</subject><issn>1543-0790</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j8tKxDAYRrNQnLH6CpKlm0Lul2UZvEEGN-O6JM1fJtKbTSv49hYcV-dbfBw4V2hPpeAl0Zbs0G3On4QIqpm6QTtuNLeasT1ipzPgCN_QjVMPw4LHFm9MA07DOYW0jHPeJq6ODvsh4sq5O3Td-i7D_YUF-nh-Oh1eS_f-8naoXDkxSpdScdoI0zBltQFtgbSaECujUVIzS7wP0fIQvAEwMgJVUrEgglVEadWIyAv0-Oed5vFrhbzUfcoNdJ0fYFxzzYkUZsvYWgr0cLmuoYdYT3Pq_fxT_3fyX9wQSyA</recordid><startdate>202405</startdate><enddate>202405</enddate><creator>Issa, Ghayas C</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202405</creationdate><title>The development of menin inhibitors in AML and ALL</title><author>Issa, Ghayas C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-631c48c26978e79e0f70095d8657290aabd93bba8ee85de16562b4b960676c4d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antineoplastic Agents - pharmacology</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Humans</topic><topic>Leukemia, Myeloid, Acute - drug therapy</topic><topic>Leukemia, Myeloid, Acute - metabolism</topic><topic>Proto-Oncogene Proteins - antagonists &amp; inhibitors</topic><topic>Proto-Oncogene Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Issa, Ghayas C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical advances in hematology &amp; oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Issa, Ghayas C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The development of menin inhibitors in AML and ALL</atitle><jtitle>Clinical advances in hematology &amp; oncology</jtitle><addtitle>Clin Adv Hematol Oncol</addtitle><date>2024-05</date><risdate>2024</risdate><volume>22</volume><issue>4</issue><spage>185</spage><epage>187</epage><pages>185-187</pages><issn>1543-0790</issn><cop>United States</cop><pmid>38739722</pmid><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1543-0790
ispartof Clinical advances in hematology & oncology, 2024-05, Vol.22 (4), p.185-187
issn 1543-0790
language eng
recordid cdi_proquest_miscellaneous_3054839787
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Antineoplastic Agents - pharmacology
Antineoplastic Agents - therapeutic use
Humans
Leukemia, Myeloid, Acute - drug therapy
Leukemia, Myeloid, Acute - metabolism
Proto-Oncogene Proteins - antagonists & inhibitors
Proto-Oncogene Proteins - metabolism
title The development of menin inhibitors in AML and ALL
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T12%3A43%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20development%20of%20menin%20inhibitors%20in%20AML%20and%20ALL&rft.jtitle=Clinical%20advances%20in%20hematology%20&%20oncology&rft.au=Issa,%20Ghayas%20C&rft.date=2024-05&rft.volume=22&rft.issue=4&rft.spage=185&rft.epage=187&rft.pages=185-187&rft.issn=1543-0790&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E3054839787%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3054839787&rft_id=info:pmid/38739722&rfr_iscdi=true